nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—PPARG—Sulfasalazine—ankylosing spondylitis	0.335	0.383	CbGbCtD
Pioglitazone—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.115	0.132	CbGbCtD
Pioglitazone—PTGS1—Sulfasalazine—ankylosing spondylitis	0.0844	0.0965	CbGbCtD
Pioglitazone—SLCO1B3—Methotrexate—ankylosing spondylitis	0.0793	0.0906	CbGbCtD
Pioglitazone—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0462	0.0528	CbGbCtD
Pioglitazone—CYP2C19—Prednisone—ankylosing spondylitis	0.0327	0.0373	CbGbCtD
Pioglitazone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0261	0.0298	CbGbCtD
Pioglitazone—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0243	0.0278	CbGbCtD
Pioglitazone—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0204	0.0233	CbGbCtD
Pioglitazone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0198	0.0226	CbGbCtD
Pioglitazone—CYP2C9—Dexamethasone—ankylosing spondylitis	0.017	0.0194	CbGbCtD
Pioglitazone—CYP3A4—Betamethasone—ankylosing spondylitis	0.0169	0.0194	CbGbCtD
Pioglitazone—CYP3A4—Prednisolone—ankylosing spondylitis	0.0167	0.0191	CbGbCtD
Pioglitazone—CYP3A4—Prednisone—ankylosing spondylitis	0.0158	0.018	CbGbCtD
Pioglitazone—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0155	0.0177	CbGbCtD
Pioglitazone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00986	0.0113	CbGbCtD
Pioglitazone—Cardiac failure congestive—Dexamethasone—ankylosing spondylitis	0.000582	0.00465	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Betamethasone—ankylosing spondylitis	0.000582	0.00465	CcSEcCtD
Pioglitazone—Injury—Dexamethasone—ankylosing spondylitis	0.000575	0.00459	CcSEcCtD
Pioglitazone—Injury—Betamethasone—ankylosing spondylitis	0.000575	0.00459	CcSEcCtD
Pioglitazone—Pulmonary oedema—Prednisone—ankylosing spondylitis	0.000564	0.00451	CcSEcCtD
Pioglitazone—Increased appetite—Betamethasone—ankylosing spondylitis	0.000562	0.00449	CcSEcCtD
Pioglitazone—Increased appetite—Dexamethasone—ankylosing spondylitis	0.000562	0.00449	CcSEcCtD
Pioglitazone—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	0.00056	0.00447	CcSEcCtD
Pioglitazone—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.000557	0.00445	CcSEcCtD
Pioglitazone—Visual disturbance—Betamethasone—ankylosing spondylitis	0.000557	0.00445	CcSEcCtD
Pioglitazone—Cardiac failure—Betamethasone—ankylosing spondylitis	0.000541	0.00432	CcSEcCtD
Pioglitazone—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.000541	0.00432	CcSEcCtD
Pioglitazone—Diabetes mellitus—Prednisone—ankylosing spondylitis	0.000529	0.00422	CcSEcCtD
Pioglitazone—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.000525	0.00419	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.000512	0.00409	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Prednisone—ankylosing spondylitis	0.000507	0.00405	CcSEcCtD
Pioglitazone—Influenza—Triamcinolone—ankylosing spondylitis	0.000503	0.00402	CcSEcCtD
Pioglitazone—Injury—Prednisone—ankylosing spondylitis	0.0005	0.004	CcSEcCtD
Pioglitazone—Weight increased—Prednisolone—ankylosing spondylitis	0.000498	0.00398	CcSEcCtD
Pioglitazone—Increased appetite—Prednisone—ankylosing spondylitis	0.00049	0.00391	CcSEcCtD
Pioglitazone—Bronchitis—Triamcinolone—ankylosing spondylitis	0.000484	0.00387	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.000481	0.00384	CcSEcCtD
Pioglitazone—Neoplasm—Methotrexate—ankylosing spondylitis	0.000479	0.00383	CcSEcCtD
Pioglitazone—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.000478	0.00382	CcSEcCtD
Pioglitazone—Pulmonary oedema—Methotrexate—ankylosing spondylitis	0.000471	0.00377	CcSEcCtD
Pioglitazone—Cardiac failure—Prednisone—ankylosing spondylitis	0.000471	0.00377	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.000468	0.00374	CcSEcCtD
Pioglitazone—Weight increased—Triamcinolone—ankylosing spondylitis	0.000458	0.00366	CcSEcCtD
Pioglitazone—Weight increased—Methylprednisolone—ankylosing spondylitis	0.000457	0.00365	CcSEcCtD
Pioglitazone—Infestation—Methylprednisolone—ankylosing spondylitis	0.000448	0.00358	CcSEcCtD
Pioglitazone—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000448	0.00358	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.000442	0.00353	CcSEcCtD
Pioglitazone—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.000442	0.00353	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.000441	0.00353	CcSEcCtD
Pioglitazone—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.00044	0.00351	CcSEcCtD
Pioglitazone—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.000439	0.00351	CcSEcCtD
Pioglitazone—Sweating—Methylprednisolone—ankylosing spondylitis	0.000429	0.00343	CcSEcCtD
Pioglitazone—Hepatic failure—Methotrexate—ankylosing spondylitis	0.000428	0.00342	CcSEcCtD
Pioglitazone—Visual impairment—Prednisolone—ankylosing spondylitis	0.000422	0.00337	CcSEcCtD
Pioglitazone—Weight increased—Dexamethasone—ankylosing spondylitis	0.000416	0.00332	CcSEcCtD
Pioglitazone—Weight increased—Betamethasone—ankylosing spondylitis	0.000416	0.00332	CcSEcCtD
Pioglitazone—Weight decreased—Dexamethasone—ankylosing spondylitis	0.000413	0.0033	CcSEcCtD
Pioglitazone—Weight decreased—Betamethasone—ankylosing spondylitis	0.000413	0.0033	CcSEcCtD
Pioglitazone—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000412	0.00329	CcSEcCtD
Pioglitazone—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000412	0.00329	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.000406	0.00324	CcSEcCtD
Pioglitazone—Visual disturbance—Methotrexate—ankylosing spondylitis	0.000406	0.00324	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000401	0.00321	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000401	0.00321	CcSEcCtD
Pioglitazone—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.0004	0.00319	CcSEcCtD
Pioglitazone—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000399	0.00319	CcSEcCtD
Pioglitazone—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000399	0.00319	CcSEcCtD
Pioglitazone—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000395	0.00315	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.000392	0.00313	CcSEcCtD
Pioglitazone—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000387	0.00309	CcSEcCtD
Pioglitazone—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000376	0.003	CcSEcCtD
Pioglitazone—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000373	0.00298	CcSEcCtD
Pioglitazone—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.000366	0.00293	CcSEcCtD
Pioglitazone—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000363	0.0029	CcSEcCtD
Pioglitazone—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000362	0.00289	CcSEcCtD
Pioglitazone—Weight increased—Prednisone—ankylosing spondylitis	0.000362	0.00289	CcSEcCtD
Pioglitazone—Weight decreased—Prednisone—ankylosing spondylitis	0.00036	0.00287	CcSEcCtD
Pioglitazone—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000359	0.00287	CcSEcCtD
Pioglitazone—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000355	0.00284	CcSEcCtD
Pioglitazone—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000354	0.00283	CcSEcCtD
Pioglitazone—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000352	0.00281	CcSEcCtD
Pioglitazone—Visual impairment—Betamethasone—ankylosing spondylitis	0.000352	0.00281	CcSEcCtD
Pioglitazone—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00035	0.00279	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000349	0.00279	CcSEcCtD
Pioglitazone—Angioedema—Prednisolone—ankylosing spondylitis	0.000348	0.00278	CcSEcCtD
Pioglitazone—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000348	0.00278	CcSEcCtD
Pioglitazone—Breast disorder—Methotrexate—ankylosing spondylitis	0.000347	0.00278	CcSEcCtD
Pioglitazone—Malaise—Prednisolone—ankylosing spondylitis	0.000344	0.00275	CcSEcCtD
Pioglitazone—Vertigo—Prednisolone—ankylosing spondylitis	0.000343	0.00274	CcSEcCtD
Pioglitazone—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000342	0.00273	CcSEcCtD
Pioglitazone—Eye disorder—Betamethasone—ankylosing spondylitis	0.000342	0.00273	CcSEcCtD
Pioglitazone—Back pain—Triamcinolone—ankylosing spondylitis	0.000339	0.00271	CcSEcCtD
Pioglitazone—Hypertension—Prednisolone—ankylosing spondylitis	0.000329	0.00263	CcSEcCtD
Pioglitazone—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000325	0.0026	CcSEcCtD
Pioglitazone—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000325	0.00259	CcSEcCtD
Pioglitazone—Discomfort—Prednisolone—ankylosing spondylitis	0.000321	0.00256	CcSEcCtD
Pioglitazone—Angioedema—Triamcinolone—ankylosing spondylitis	0.00032	0.00256	CcSEcCtD
Pioglitazone—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00032	0.00255	CcSEcCtD
Pioglitazone—Malaise—Triamcinolone—ankylosing spondylitis	0.000316	0.00253	CcSEcCtD
Pioglitazone—Malaise—Methylprednisolone—ankylosing spondylitis	0.000315	0.00252	CcSEcCtD
Pioglitazone—Vertigo—Triamcinolone—ankylosing spondylitis	0.000315	0.00252	CcSEcCtD
Pioglitazone—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000314	0.00251	CcSEcCtD
Pioglitazone—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000313	0.0025	CcSEcCtD
Pioglitazone—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000311	0.00249	CcSEcCtD
Pioglitazone—Oedema—Prednisolone—ankylosing spondylitis	0.000311	0.00249	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000309	0.00247	CcSEcCtD
Pioglitazone—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000306	0.00244	CcSEcCtD
Pioglitazone—Hypertension—Triamcinolone—ankylosing spondylitis	0.000303	0.00242	CcSEcCtD
Pioglitazone—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000302	0.00241	CcSEcCtD
Pioglitazone—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000301	0.0024	CcSEcCtD
Pioglitazone—Myalgia—Triamcinolone—ankylosing spondylitis	0.000298	0.00238	CcSEcCtD
Pioglitazone—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000298	0.00238	CcSEcCtD
Pioglitazone—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000298	0.00238	CcSEcCtD
Pioglitazone—Eye disorder—Prednisone—ankylosing spondylitis	0.000297	0.00238	CcSEcCtD
Pioglitazone—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000296	0.00237	CcSEcCtD
Pioglitazone—Infestation—Methotrexate—ankylosing spondylitis	0.000296	0.00237	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000296	0.00236	CcSEcCtD
Pioglitazone—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000295	0.00236	CcSEcCtD
Pioglitazone—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000295	0.00236	CcSEcCtD
Pioglitazone—Discomfort—Triamcinolone—ankylosing spondylitis	0.000295	0.00236	CcSEcCtD
Pioglitazone—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000294	0.00235	CcSEcCtD
Pioglitazone—Angioedema—Dexamethasone—ankylosing spondylitis	0.000291	0.00232	CcSEcCtD
Pioglitazone—Angioedema—Betamethasone—ankylosing spondylitis	0.000291	0.00232	CcSEcCtD
Pioglitazone—Immune system disorder—Prednisone—ankylosing spondylitis	0.000287	0.0023	CcSEcCtD
Pioglitazone—Malaise—Betamethasone—ankylosing spondylitis	0.000287	0.00229	CcSEcCtD
Pioglitazone—Malaise—Dexamethasone—ankylosing spondylitis	0.000287	0.00229	CcSEcCtD
Pioglitazone—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000286	0.00229	CcSEcCtD
Pioglitazone—Oedema—Triamcinolone—ankylosing spondylitis	0.000286	0.00229	CcSEcCtD
Pioglitazone—Vertigo—Betamethasone—ankylosing spondylitis	0.000286	0.00228	CcSEcCtD
Pioglitazone—Vertigo—Dexamethasone—ankylosing spondylitis	0.000286	0.00228	CcSEcCtD
Pioglitazone—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000286	0.00228	CcSEcCtD
Pioglitazone—Infection—Triamcinolone—ankylosing spondylitis	0.000284	0.00227	CcSEcCtD
Pioglitazone—Sweating—Methotrexate—ankylosing spondylitis	0.000284	0.00227	CcSEcCtD
Pioglitazone—Infection—Methylprednisolone—ankylosing spondylitis	0.000284	0.00227	CcSEcCtD
Pioglitazone—Haematuria—Methotrexate—ankylosing spondylitis	0.000282	0.00226	CcSEcCtD
Pioglitazone—Insomnia—Prednisolone—ankylosing spondylitis	0.000281	0.00225	CcSEcCtD
Pioglitazone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00028	0.00224	CcSEcCtD
Pioglitazone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000277	0.00222	CcSEcCtD
Pioglitazone—Malnutrition—Prednisone—ankylosing spondylitis	0.000277	0.00221	CcSEcCtD
Pioglitazone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000277	0.00221	CcSEcCtD
Pioglitazone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000276	0.0022	CcSEcCtD
Pioglitazone—Hypertension—Dexamethasone—ankylosing spondylitis	0.000275	0.00219	CcSEcCtD
Pioglitazone—Hypertension—Betamethasone—ankylosing spondylitis	0.000275	0.00219	CcSEcCtD
Pioglitazone—Myalgia—Dexamethasone—ankylosing spondylitis	0.000271	0.00216	CcSEcCtD
Pioglitazone—Myalgia—Betamethasone—ankylosing spondylitis	0.000271	0.00216	CcSEcCtD
Pioglitazone—Discomfort—Betamethasone—ankylosing spondylitis	0.000268	0.00214	CcSEcCtD
Pioglitazone—Discomfort—Dexamethasone—ankylosing spondylitis	0.000268	0.00214	CcSEcCtD
Pioglitazone—Hepatitis—Methotrexate—ankylosing spondylitis	0.000266	0.00212	CcSEcCtD
Pioglitazone—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000264	0.00211	CcSEcCtD
Pioglitazone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000263	0.0021	CcSEcCtD
Pioglitazone—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000261	0.00208	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000261	0.00208	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00026	0.00208	CcSEcCtD
Pioglitazone—Oedema—Dexamethasone—ankylosing spondylitis	0.00026	0.00207	CcSEcCtD
Pioglitazone—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00026	0.00207	CcSEcCtD
Pioglitazone—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00026	0.00207	CcSEcCtD
Pioglitazone—Oedema—Betamethasone—ankylosing spondylitis	0.00026	0.00207	CcSEcCtD
Pioglitazone—Insomnia—Triamcinolone—ankylosing spondylitis	0.000259	0.00207	CcSEcCtD
Pioglitazone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000258	0.00206	CcSEcCtD
Pioglitazone—Infection—Betamethasone—ankylosing spondylitis	0.000258	0.00206	CcSEcCtD
Pioglitazone—Infection—Dexamethasone—ankylosing spondylitis	0.000258	0.00206	CcSEcCtD
Pioglitazone—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000257	0.00205	CcSEcCtD
Pioglitazone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000256	0.00205	CcSEcCtD
Pioglitazone—Visual impairment—Methotrexate—ankylosing spondylitis	0.000256	0.00205	CcSEcCtD
Pioglitazone—Anaemia—Prednisone—ankylosing spondylitis	0.000256	0.00205	CcSEcCtD
Pioglitazone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000255	0.00204	CcSEcCtD
Pioglitazone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000255	0.00203	CcSEcCtD
Pioglitazone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000255	0.00203	CcSEcCtD
Pioglitazone—Angioedema—Prednisone—ankylosing spondylitis	0.000253	0.00202	CcSEcCtD
Pioglitazone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000251	0.002	CcSEcCtD
Pioglitazone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000251	0.002	CcSEcCtD
Pioglitazone—Malaise—Prednisone—ankylosing spondylitis	0.00025	0.002	CcSEcCtD
Pioglitazone—Vertigo—Prednisone—ankylosing spondylitis	0.000249	0.00199	CcSEcCtD
Pioglitazone—Eye disorder—Methotrexate—ankylosing spondylitis	0.000249	0.00199	CcSEcCtD
Pioglitazone—Urticaria—Prednisolone—ankylosing spondylitis	0.000247	0.00197	CcSEcCtD
Pioglitazone—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000247	0.00197	CcSEcCtD
Pioglitazone—Fatigue—Triamcinolone—ankylosing spondylitis	0.000247	0.00197	CcSEcCtD
Pioglitazone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000246	0.00197	CcSEcCtD
Pioglitazone—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00024	0.00192	CcSEcCtD
Pioglitazone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00024	0.00191	CcSEcCtD
Pioglitazone—Hypertension—Prednisone—ankylosing spondylitis	0.000239	0.00191	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000237	0.00189	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000237	0.00189	CcSEcCtD
Pioglitazone—Arthralgia—Prednisone—ankylosing spondylitis	0.000236	0.00188	CcSEcCtD
Pioglitazone—Myalgia—Prednisone—ankylosing spondylitis	0.000236	0.00188	CcSEcCtD
Pioglitazone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000236	0.00188	CcSEcCtD
Pioglitazone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000235	0.00188	CcSEcCtD
Pioglitazone—Insomnia—Betamethasone—ankylosing spondylitis	0.000235	0.00188	CcSEcCtD
Pioglitazone—Insomnia—Dexamethasone—ankylosing spondylitis	0.000235	0.00188	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000234	0.00187	CcSEcCtD
Pioglitazone—Discomfort—Prednisone—ankylosing spondylitis	0.000233	0.00186	CcSEcCtD
Pioglitazone—Malnutrition—Methotrexate—ankylosing spondylitis	0.000232	0.00185	CcSEcCtD
Pioglitazone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000229	0.00183	CcSEcCtD
Pioglitazone—Urticaria—Triamcinolone—ankylosing spondylitis	0.000227	0.00182	CcSEcCtD
Pioglitazone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000227	0.00181	CcSEcCtD
Pioglitazone—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000226	0.00181	CcSEcCtD
Pioglitazone—Oedema—Prednisone—ankylosing spondylitis	0.000226	0.00181	CcSEcCtD
Pioglitazone—Infection—Prednisone—ankylosing spondylitis	0.000225	0.00179	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000224	0.00179	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000224	0.00179	CcSEcCtD
Pioglitazone—Back pain—Methotrexate—ankylosing spondylitis	0.000224	0.00179	CcSEcCtD
Pioglitazone—Fatigue—Betamethasone—ankylosing spondylitis	0.000224	0.00179	CcSEcCtD
Pioglitazone—Fatigue—Dexamethasone—ankylosing spondylitis	0.000224	0.00179	CcSEcCtD
Pioglitazone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000222	0.00177	CcSEcCtD
Pioglitazone—Skin disorder—Prednisone—ankylosing spondylitis	0.00022	0.00175	CcSEcCtD
Pioglitazone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000219	0.00175	CcSEcCtD
Pioglitazone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000215	0.00172	CcSEcCtD
Pioglitazone—Anaemia—Methotrexate—ankylosing spondylitis	0.000214	0.00171	CcSEcCtD
Pioglitazone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000214	0.00171	CcSEcCtD
Pioglitazone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000214	0.00171	CcSEcCtD
Pioglitazone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000211	0.00168	CcSEcCtD
Pioglitazone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00021	0.00168	CcSEcCtD
Pioglitazone—Malaise—Methotrexate—ankylosing spondylitis	0.000209	0.00167	CcSEcCtD
Pioglitazone—Vertigo—Methotrexate—ankylosing spondylitis	0.000208	0.00166	CcSEcCtD
Pioglitazone—Urticaria—Dexamethasone—ankylosing spondylitis	0.000206	0.00165	CcSEcCtD
Pioglitazone—Urticaria—Betamethasone—ankylosing spondylitis	0.000206	0.00165	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000206	0.00165	CcSEcCtD
Pioglitazone—Dizziness—Prednisolone—ankylosing spondylitis	0.000206	0.00164	CcSEcCtD
Pioglitazone—Asthenia—Triamcinolone—ankylosing spondylitis	0.000205	0.00164	CcSEcCtD
Pioglitazone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000205	0.00164	CcSEcCtD
Pioglitazone—Insomnia—Prednisone—ankylosing spondylitis	0.000205	0.00163	CcSEcCtD
Pioglitazone—Chest pain—Methotrexate—ankylosing spondylitis	0.000197	0.00157	CcSEcCtD
Pioglitazone—Arthralgia—Methotrexate—ankylosing spondylitis	0.000197	0.00157	CcSEcCtD
Pioglitazone—Myalgia—Methotrexate—ankylosing spondylitis	0.000197	0.00157	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000196	0.00156	CcSEcCtD
Pioglitazone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000195	0.00156	CcSEcCtD
Pioglitazone—Fatigue—Prednisone—ankylosing spondylitis	0.000195	0.00156	CcSEcCtD
Pioglitazone—Headache—Prednisolone—ankylosing spondylitis	0.000195	0.00156	CcSEcCtD
Pioglitazone—Discomfort—Methotrexate—ankylosing spondylitis	0.000195	0.00156	CcSEcCtD
Pioglitazone—Dizziness—Triamcinolone—ankylosing spondylitis	0.000189	0.00151	CcSEcCtD
Pioglitazone—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000189	0.00151	CcSEcCtD
Pioglitazone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000189	0.00151	CcSEcCtD
Pioglitazone—Infection—Methotrexate—ankylosing spondylitis	0.000188	0.0015	CcSEcCtD
Pioglitazone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000186	0.00149	CcSEcCtD
Pioglitazone—Asthenia—Betamethasone—ankylosing spondylitis	0.000186	0.00149	CcSEcCtD
Pioglitazone—Asthenia—Dexamethasone—ankylosing spondylitis	0.000186	0.00149	CcSEcCtD
Pioglitazone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000185	0.00148	CcSEcCtD
Pioglitazone—Skin disorder—Methotrexate—ankylosing spondylitis	0.000184	0.00147	CcSEcCtD
Pioglitazone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000183	0.00146	CcSEcCtD
Pioglitazone—Urticaria—Prednisone—ankylosing spondylitis	0.00018	0.00143	CcSEcCtD
Pioglitazone—Headache—Triamcinolone—ankylosing spondylitis	0.000179	0.00143	CcSEcCtD
Pioglitazone—Headache—Methylprednisolone—ankylosing spondylitis	0.000179	0.00143	CcSEcCtD
Pioglitazone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000178	0.00142	CcSEcCtD
Pioglitazone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000178	0.00142	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000172	0.00138	CcSEcCtD
Pioglitazone—Dizziness—Dexamethasone—ankylosing spondylitis	0.000172	0.00137	CcSEcCtD
Pioglitazone—Dizziness—Betamethasone—ankylosing spondylitis	0.000172	0.00137	CcSEcCtD
Pioglitazone—Insomnia—Methotrexate—ankylosing spondylitis	0.000171	0.00137	CcSEcCtD
Pioglitazone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000168	0.00135	CcSEcCtD
Pioglitazone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000167	0.00133	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000163	0.0013	CcSEcCtD
Pioglitazone—Fatigue—Methotrexate—ankylosing spondylitis	0.000163	0.0013	CcSEcCtD
Pioglitazone—Headache—Dexamethasone—ankylosing spondylitis	0.000163	0.0013	CcSEcCtD
Pioglitazone—Headache—Betamethasone—ankylosing spondylitis	0.000163	0.0013	CcSEcCtD
Pioglitazone—Asthenia—Prednisone—ankylosing spondylitis	0.000162	0.0013	CcSEcCtD
Pioglitazone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000156	0.00124	CcSEcCtD
Pioglitazone—Diarrhoea—Prednisone—ankylosing spondylitis	0.000155	0.00124	CcSEcCtD
Pioglitazone—Urticaria—Methotrexate—ankylosing spondylitis	0.00015	0.0012	CcSEcCtD
Pioglitazone—Dizziness—Prednisone—ankylosing spondylitis	0.00015	0.00119	CcSEcCtD
Pioglitazone—Headache—Prednisone—ankylosing spondylitis	0.000142	0.00113	CcSEcCtD
Pioglitazone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000139	0.00111	CcSEcCtD
Pioglitazone—Asthenia—Methotrexate—ankylosing spondylitis	0.000136	0.00108	CcSEcCtD
Pioglitazone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000129	0.00103	CcSEcCtD
Pioglitazone—Dizziness—Methotrexate—ankylosing spondylitis	0.000125	0.000998	CcSEcCtD
Pioglitazone—Headache—Methotrexate—ankylosing spondylitis	0.000118	0.000946	CcSEcCtD
